Guidance and criteria for authorship can be found in our editorial policies. Awareness of predatory journals did not correlate with gender (p=0.515) or translation of scientific literature into clinical practice (p=0.543). Gemcitabine requires transport into cells and activation by phosphorylation, the resulting gemcitabine triphosphate is incorporated into newly synthesized DNA during cell division, inhibiting further DNA synthesis and causing cell death. Footnotes to the text are numbered consecutively; those to tables should be indicated by superscript lower-case letters (or asterisks for significance values and other statistical data). According to Sahu et al., COVID-19 epidemic is the third most common coronavirus in the 21st century, resulting in numerous deaths all over the world. Assessment of joint bleeding and target joints in patients with severe or moderately severe hemophilia B (factor IX ≤2%) receiving prophylaxis with rIX-FP in the PROLONG-9FP clinical trial program. You can add institution or country information for each author if you wish, but this should be consistent across all authors. Multiple myeloma (MM) is a common hematologic malignancy, with 32,110 new cases diagnosed in the United States in 2019, resulting in 12,960 deaths. You should not send the form to us on submission, but we may request to see a copy at any stage (including after publication). Online ISSN: 2572-9241. Journal of Clinical Haematology is intended to publish latest discoveries in the field of Haematology. All data generated or analysed during this study are included in this published article [and its supplementary information files]. About Cell Journal Cell is a peer-reviewed scientific journal publishing research papers across a broad range of disciplines within the life sciences. present a title that includes, if appropriate, the study design e.g. Title of subordinate document. The future is open access, and we are here to support you. Mantle cell lymphoma (MCL) is a rare subtype of non- Hodgkin Lymphoma (NHL) characterized by cyclin D1 translocations. Advertisement. VEXAS Syndrome in a Patient with Myeloproliferative Neoplasia. The impact factor is calculated by dividing the number of times the articles are cited in the last two years by the total number of publications in those two years. The individual contributions of authors to the manuscript should be specified in this section. If you would like to meet in person, please email at haematology@lancet.com. New associations or variations in disease processes. An acute lymphoblastic leukemia-based treatment regimen was ineffective, but azacitidine and venetoclax therapy resulted in hematological complete remission. Experimental Research. ASH Commitment to Diversity, Equity, and Inclusion in Health Care. The Chinese American Hematologist and Oncologist Network (CAHON) has published an important and timely Editorial in the Journal of Hematology & Oncology. Gemcitabine is a synthetic pyrimidine nucleoside analogue which is administered intravenously as a chemotherapeutic to treat numerous cancers. Imatinib Resistance in Chronic Myeloid Leukemia Associated with a D363G BCR::ABL1 Kinase Domain Mutation. Mixed phenotype acute leukemia (MPAL) is characterized by leukemic blasts that express markers of multiple lineages. The data that support the findings of this study are available from [third party name] but restrictions apply to the availability of these data, which were used under license for the current study, and so are not publicly available. With this article, we want to present a case history of a man in his sixties with a JAK2V617F mutated essential thrombocythemia (ET) developing VEXAS syndrome. Journal name. The objective of this study was to evaluate elderly patients’ survival with de novo AML and acute myeloid leukemia myelodysplasia-related (AML-MR), treated with intensive and less-intensive chemotherapy and supportive care. Journal of Hematology & Oncology is the official journal of the Chinese American Hematologist and Oncologist Network. At least 55% of the lymphocytes in the peripheral blood must be prolymphocytes to be defined as B-PLL. At least 55% of the lymphocytes in the peripheral blood must be prolymphocytes to be defined as B-PLL. We are proud to stand with them in denouncing in the strongest terms all forms of discrimination and crimes against any racial/ethnic group, including Asian Americans and Pacific Islanders, and to call on our readers to pursue racial equality and tolerance in the USA and beyond. Safety and Tolerability of Nilotinib in Patients with Chronic Myeloid Leukemia during Routine Clinical Practice: Results from the ERASER Study from Greece. Brain Tumor Awareness Month: Can proton beam therapy improve the long-term quality of life of patients with oligodendroglioma brain tumors? The Impact Factor of journal J in the calendar year X is the number of citations received by J in X to any item published in J in (X-1) or (X-2), divided by the number of source items published in J in (X-1) or (X-2). Blood Advances is an open-access, online journal that publishes more peer-reviewed hematology research than any other academic journal worldwide. Editor-in-ChiefFarhad Ravandi, MD, ProfessorJaniece and Stephen A. Lasher Professor of MedicineChief, Section of Acute Myeloid LeukemiaDepartment of LeukemiaThe University of Texas MD Anderson Cancer Center, Texas, USA Read more...ISSN 1927-1212 print | ISSN 1927-1220 online | Bimonthly | Open Access | Aims and Scope Indexed and covered by: Chemical Abstract (CA); Worldcat; Google; Google Scholar; JournalTOCs; PubMed Central; PubMed; Web of Science (Emerging Sources Citation Index-ESCI), JCR Impact Factor: available June 2023. These hematological malignancies exhibit different tumor behavior and are responsive to different chemotherapy agents which impacts clinical outcomes. We welcome researchers, academicians, and clinicians to publish their latest impactful discoveries in our journal. HemaSphere is proud to have a 2021 Journal Impact Factor (JIF) of 8.3. For randomised studies, the assessment was based on . About 26% of people will expire from NHL (15% males and 11% females).Non-Hodgkin lymphoma arises from the clonal expansion of B, T, and natural killer (NK) cells. There is a significant degree of heterogeneity in NHL and this is likely related to different degrees of differentiation and maturation of these cells. Latest Journal's Impact IF - Trend · Prediction · Ranking · Key Factor ... Physiology, Coagulation Cascade: Inherited Disorders, and the Molecular Phenomenon of Alterations in Hemostasis, The physiology of coagulation routes and paths is a cascade of several molecular phenomena and biological events which was classified into two categories based on their phenomena i.e., intrinsic and extrinsic, originated separately, consisting of various factors and features such as fibrinogen, prothrombin, plasma thromboplastin, Hageman factor, Christmas factor, and Stuart-Prower factor, participate in its physiology, Lower 24-Month Relative Survival among Black Patients with Non- Hodgkin’s Lymphoma: An Analysis of the SEER Data 1997-2015. Existing literature is limited to case reports and small single-center retrospective series, explaining the lack of any treatment algorithms and management guidelines for patients with this disorder. The syndrome is a combined hematological and rheumatological condition caused by a somatic mutation in the UBA1. Data citations should include a persistent identifier (such as a DOI) and should ideally be included in the reference list. Journal of Clinical Haematology is a highly reputed international journal dedicated to publish outstanding advances in vascular biology and haematology. An image of a cartoon face that is very unhappy. Zheng L-Y, Guo X-S, He B, Sun L-J, Peng Y, Dong S-S, et al. We offer a free open access support service to make it easier for you to discover and apply for article-processing charge (APC) funding. His major complaint was stiffness and pain, and high dosages of prednisolone were necessary to obtain pain relief. Clinical Hematology International is the official journal of the International Academy for Clinical Hematology (IACH). Including PIH articles on Stem cell regulation and dynamics in myeloid malignancies. About this journal Editor spotlight If any of the sections are not relevant to your manuscript, please include the heading and write 'Not applicable' for that section. : "A versus B in the treatment of C: a randomized controlled trial", "X is a risk factor for Y: a case control study", "What is the impact of factor X on subject Y: A systematic review, A case report etc. He could not get pain relief unless the combination of medications included a relatively high dose of prednisolone. Hematology Reports | An Open Access Journal from MDPI Diagnosis is usually made by demonstration of decreased PK enzymatic activity in a spectrophotometric assay and on the detection of mutations in the PK-LR gene. The journal is not supported and does not receive any funding from any commercial entity, beside the academic support described above. A case of CML is described in which presence of a rare D363G BCR::ABL1 KDM resulted in a suboptimal response to frontline imatinib. A. M. M. Elshaier, Maria J Nieto, Zhen Li, Hasan Rehman, Muhammad Wasif Saif. They release bio-active proteins and other active ingredients that can affect a number of phenomena that promote cell consumption, growth and transformation (growth factors). This Journal of Hematology & Oncology and Experimental Hematology & Oncology series intends to publish Correspondences with latest updates on novel agents and regimens from major conferences on blood and cancer disorders. American Society of Hematology. Manuscripts reporting studies involving human participants, human data or human tissue must: Studies involving animals must include a statement on ethics approval and for experimental studies involving client-owned animals, authors must also include a statement on informed consent from the client or owner. The information below details the section headings that you should include in your manuscript and what information should be within each section. We recognise it is not always possible to share research data publicly, for instance when individual privacy could be compromised, and in such instances data availability should still be stated in the manuscript along with any conditions for access. Journal of Clinical Haematology is intended to publish latest discoveries in the field of Haematology. Blood 2021 Impact Factor: 25.669. 2.4. Doe, J: Trivial HTTP, RFC2169. Best Practice & Research Clinical Haematology provides a comprehensive review of current clinical practice and thinking within the specialty of haematology. Note this section should not be used to describe any competing interests. 5 Year Impact Factor*: the average number of citations received by articles in the journal within a five-year window. Brain Tumor Awareness Month: Can proton beam therapy improve the long-term quality of life of patients with oligodendroglioma brain tumors? Currently, the patient uses prednisolone, anagrelide, and ruxolitinib, with partial remission and fewer hospitalizations and more stabilized hemoglobin and thrombocytes. International Journal of Hematology | Home - Springer Learn more about International Academy for Clinical Hematology (IACH), its activities and Conflict of Interest policy. Article within a journal (no page numbers). About Nature Catalysis Journal Nature Catalysis is a peer-reviewed journal from Nature Publishing Group. Case Reports in Hematology maintains an Editorial Board of practicing researchers from around the world, to ensure manuscripts are handled by editors who are experts in the field of study. With an impact factor of 25.476 (2021), . Very stringent measures are implemented to ensure the total independence, unbiased nature, and integrity of the journal. Each Correspondence serves as a summary and analysis of 5 or more abstracts on a similar focus from a major international conference. Accessed 15 Jan 1999. Top 100 Highest Impact Factor Journals of 2022 For patients with indolent clinical behavior, observation is frequently employed, and large case series suggest the possibility of prolonged periods before treatment becomes necessary, as long as 128 months, and favorable outcomes even once treatment has been initiated. The British Journal of Haematology publishes original research papers in clinical, laboratory and experimental haematology. Clinical Hematology International has been successfully indexed in Scopus in January 2023. There are not many descriptions of patients having VEXAS in combination with myeloproliferative neoplasm (MPN). See our editorial policies for author guidance on good citation practice. Blood is composed of blood cells suspended in plasma. Peter Brændstrup, Dennis Lund Hansen, Louise Kristensen, Henrik Frederiksen, Hanne E. H. Møller, Rachel Rose Hall, Christine MG Schammel, Jennifer Bell Knight, Katarzyna Piadel, Angus George Dalgleish, Peter Lawrence Smith, Diksha Rewal, Sanjay Prakash, Rajaram Sharma, P.M.A.S Senevirathna, K.D.J.M.K Galahitiyawa, D.M.N.K Dassanayake, N.K.K.S Thabrew, Argiris Symeonidis, Achilles Anagnostopoulos, Maria Ximeri, Georgia Kaiafa, Eleni Kapsali, Nora Athina Viniou, Theodoros Marinakis, Dimitrios Karakasis, Vasiliki Pappa, George Vassilopoulos, Dimitrios Margaritis, Maria Tabitsika, Maria Dimou, Xu Hannah Zhang, Jack Hsiang, Steven T. Rosen, Chang-Sook Hong, Michael Boyiadzis, Theresa L. Whiteside, Alessandro Crisci, Carlo Alberto Minniti , Antonella Conte, Michela Crisci, Federica Cardillo, Mahdieh Motie, Reza Dehnavieh, Khalil Kalavani, A. I. Khodair, M. K. Awad, J. P. Gesson, Y. Reporting of such cases is important for the future management of any CML patients with this rare mutation. (For the last 12-month published articles), Original Article Review Case Report Short Communication Letter to the Editor Editorial, *Average article statistics from the last 12 months data. Springer Nature. About Frontiers in Neuroscience Journal Frontiers in Neuroscience is part of the world’s most cited neuroscience journal series. (plasma being the primary medium for excretory product transportation). Having VEXAS syndrome in mind, genetic testing identifying the UBA1 gene mutation was performed, thus confirming our suspicion. Cookies policy. Please acknowledge anyone who contributed towards the article who does not meet the criteria for authorship including anyone who provided professional writing services or materials. See our editorial policies for more information. eJHaem - Wiley Online Library Find out more about where and how the content of this journal is available. Mantle Cell Lymphoma and Hematopoietic Cell Transplantation in the Era of Cellular Therapy. © International Academy for Clinical Hematology, Not logged in Please use initials to refer to each author's contribution in this section, for example: "FC analyzed and interpreted the patient data regarding the hematological disease and the transplant. By using this website, you agree to our US Pharmacopeia, Rockville. This journal's articles appear in a wide range of abstracting and indexing databases, and are covered by numerous other services that aid discovery and access. It provides an international forum for the publication of original articles describing basic laboratory, translational, and clinical investigations in hematology. Book chapter, or an article within a book. Privacy Our case suggests that multilineage lymphoblastic lymphoma should be considered to be the same disease as MPAL, albeit with different clinical presentations. Throughout the course of his condition, several attempts with prednisolone tapering and steroid sparing drugs were tried. The inflammatory symptoms occurred three and a half years after the ET diagnosis. Blood 1979;59 Suppl 1:26-32. Please note that individual names may not be present in the PubMed record at the time a published article is initially included in PubMed as it takes PubMed additional time to code this information. The journal is published by Springer quarterly as an open access peer-reviewed journal. © 2023 Springer Nature Switzerland AG. HemaSphere - LWW The first issue of Clinical Hematology International was published March 1, 2019. When Should Transplant Physicians Think about Familial Blood Cancers? VEXAS syndrome stands for vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome. Development and applications of organoids, 3D cultures, PDX modes, nano-molecules, AI technology, and single-cell maps for drug discovery will be the focus. Switching to dasatinib resulted in achieving a sustained major molecular response that was maintained after a subsequent switch to bosutinib due to the side effects. Scientific Archives is one of the emerging academic publishers in Medicine, Science and Technology. figshare. Additionally, even across SOX11 positive cases outcomes vary, with worse overall survival in MCL with cytoplasmic staining as compared to nuclear staining. Limping in children is a common complaint made at pediatric, pediatric orthopedic and in emergency departments. Journal of Clinical Oncology - ASCO Publications The sickle cell trait (SCT) disorder possesses a clinical heterogeneity ranging from a symptomless condition to sudden death. . Plasma, which constitutes 55% of body fluid, is mostly water (92% by volume) and contains proteins, glucose, mineral ions, hormones, carbon dioxide, urea, uric acid, oxygen, etc. More IF Trend, Prediction, Ranking & Key Factor Analysis. Thromboembolic events are also common in JAK2 mutated patients, but in his case, they presented first after VEXAS had developed. Saito Y, Hyuga H. Rate equation approaches to amplification of enantiomeric excess and chiral symmetry breaking. There are patients who can be cured with current regimens; however, subtypes such as indolent and some aggressive lymphomas remain incurable necessitating treatment with new therapies including immunotherapy, targeted therapy, CAR T cells, and hematopoietic stem cell transplant. Please add authors in the format First Name, Middle initial(s) (optional), Last Name. Anticancer Activity of S-Glycosylated Quinazoline Derivatives. The expanded Progress in Hematology section integrates such relevant fields as the cell biology of stem cells and cancer cells, and clinical research in inflammation, cancer, and thrombosis. Compared with acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL), MPAL is considered to have a poor treatment outcome. The Journal also features annotations, reviews, short reports, images in haematology and Letters to the Editor. This series calls for clinical studies on novel agents for cancers and blood disorders. JIF Quartile. We present the case of a patient who developed severe thrombocytopenia within twenty-four hours following the Pfizer-BioNTech vaccination. This series covers new technology, materials, and models for drug discovery. http://www.issn.org (2006). All cells produce EVs, which freely circulate and are found in all body fluids. © 2023 Springer Nature Switzerland AG. Acute myeloid leukemia (AML) arising from myeloproliferative neoplasms (MPNs) represents a small subtype of secondary AML (sAML). This official journal of the Japanese Society of Hematology covers all aspects of the field of hematology, namely, erythrocytes, leukocytes and hematopoiesis, hemostasis, thrombosis and vascular biology, hematological malignancies, transplantation, and cell therapy. reporting that they would definitely or probably, How to publish with us, including Open Access, Venetoclax with CAG regimen for early T-cell precursor acute lymphoblastic leukemia: a case report and literature review, Clinical characteristics and prognosis of a Chinese cohort with systemic light chain amyloidosis: a single-center study, Transcriptome sequencing identifies novel EVX fusions involved in transcriptional activation of HOX family genes in pediatric immature T-cell acute lymphoblastic leukemia: two cases reports and a literature review, New onset of hypomegakaryocytic thrombocytopenia with the potential for progression to aplastic anemia after BNT162b2 mRNA COVID-19 vaccination, Post-transplant maintenance therapy in acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation harmonizing multiple therapeutic modalities including targeted therapy, immunotherapy and cellular therapy, IJH Gateway (Portal for International Journal of Hematology), Japanese Science and Technology Agency (JST). Challenges persist in obtaining primary country-level data on low back . Vaccination against COVID-19 has been approved for the following three vaccines in the United States: Pfizer-BioNTech, Moderna, and Janssen. JCR, Web Of Science (PDF) - Journal Impact Factor If abbreviations are used in the text they should be defined in the text at first use, and a list of abbreviations should be provided. © 2023 BioMed Central Ltd unless otherwise stated. We present a case of a patient with PKD who demonstrated priapism to be a thromboembolic complication. Discover the range of academic oncology titles at Springer Nature here. Erdheim–Chester disease (ECD), a rare form of non-Langerhans histiocytosis, is a multisystem disorder. Information for authors: find out how to format your research paper and related materials for submission to The Lancet Haematology . The coronavirus disease 2019 (COVID-19) pandemic has affected millions of people around the world. Total Citations in 2020 and 2021 = 500. Langerhans cell histiocytosis (LCH) is a rare, clonal, haematological disease of myeloid origin involving infiltration of neoplastic cells resembling Langerhans cells in various tissues. Prospective authors should contact the Editorial Office at Aoife.Buckley@springernature.com with an outline of their paper, the lead author name, and institution. Journal of Clinical Haematology | Home Page - Scientific Archives If your manuscript does not report on or involve the use of any animal or human data or tissue, please state “Not applicable” in this section. It is issued monthly, both in print and electronically. Experimental Hematology | Journal | ScienceDirect.com by Elsevier Springer Nature. In: The dictionary of substances and their effects. Different types of leukemia have a different line of treatment and prognosis. This study aimed to develop a diagnostic approach that helps the characterization and identification of SCT from normal subjects and sickle cell disease (SCD) patients, and to assess its severity. They should not consist solely of a reference citation, and they should never include the bibliographic details of a reference. Here is the latest JCR Impact Factor 2022 provided by the Journal Citation Report (JCR). ", Prof Delong Liu, Editor-in-Chief, Journal of Hematology & Oncology, Your browser needs to have JavaScript enabled to view this timeline.
Endokrinologie Filderstadt,
Motorrad Transport Ins Ausland,
Articles J